You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Abraxane

Showing 26 - 50 of 531
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NSCLC Metastatic Trial (Atezolizumab, Nab paclitaxel, Carboplatin)

Not yet recruiting
  • Non-Small Cell Lung Cancer Metastatic
  • (no location specified)
Jan 18, 2023

Breast Tumors, Breast Cancer Trial in Houston, Sugar Land (Paclitaxel, Docetaxel, Abraxane)

Completed
Has Results
  • Breast Neoplasms
  • Breast Cancer
  • Houston, Texas
  • +2 more
Jan 19, 2023

Pancreatic Cancer, Hepatocellular Cancer, Biliary Tract Cancer Trial in Edmonton (Durvalumab, Gemcitabine, Nab paclitaxel)

Not yet recruiting
  • Pancreatic Cancer
  • +3 more
  • Durvalumab
  • +5 more
  • Edmonton, Alberta, Canada
    Cross Cancer Institute
Feb 1, 2023

Pancreatic Adenocarcinoma, Resectable Pancreatic Cancer Trial (Nab paclitaxel, Gemcitabine, NovoTTF-200T)

Not yet recruiting
  • Pancreatic Adenocarcinoma
  • Resectable Pancreatic Cancer
  • Nab paclitaxel
  • +2 more
  • (no location specified)
Dec 5, 2022

Pancreatic Cancer Trial in Boston, Philadelphia (Gemcitabine, Nab-paclitaxel, Paricalcitol)

Active, not recruiting
  • Pancreatic Cancer
  • Boston, Massachusetts
  • +1 more
Jan 9, 2023

Locally Advanced Breast Carcinoma, Metastatic Breast Carcinoma, Recurrent Breast Carcinoma Trial in United States (Laboratory

Active, not recruiting
Has Results
  • Locally Advanced Breast Carcinoma
  • +7 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Duarte, California
  • +3 more
Jan 31, 2023

NSCLC Trial in Tampa, Philadelphia (Durvalumab, Carboplatin, Abequolixron)

Not yet recruiting
  • Non-Small Cell Lung Cancer
  • Tampa, Florida
  • +1 more
Jun 9, 2023

Angiosarcoma Metastatic Trial in Guangzhou (Abraxane combined with liposomal doxorubicin)

Recruiting
  • Angiosarcoma Metastatic
  • Abraxane combined with liposomal doxorubicin
  • Guangzhou, Guangdong, China
    Xing Zhang
Sep 4, 2022

Mesothelioma Trial run by the National Cancer Institute (NCI) (LMB-100, nab-paclitaxel)

Completed
Has Results
  • Mesothelioma
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jul 28, 2022

Locally Advanced or Metastatic Solid Tumors Trial in Beijing (MSC-IFNa, Nab paclitaxel, Cyclophosphamide)

Recruiting
  • Locally Advanced or Metastatic Solid Tumors
  • MSC-IFNα
  • +3 more
  • Beijing, China
    Department of Biotherapeutic, Chinese PLA General Hospital
Jan 29, 2023

Metastatic Pancreatic Cancer Trial in Montreal (Salmonella-IL2, FOLFIRINOX Alone (Historical Controls), Gemcitabine/Abraxane

Recruiting
  • Metastatic Pancreatic Cancer
  • Montreal, Quebec, Canada
    Segal Cancer Centre/ Mortimer B. Davis-Jewish General Hosptial
May 3, 2022

Pembrolizumab and Nab-paclitaxel in HER-2 Negative Metastatic

Active, not recruiting
  • Breast Cancer
  • New York, New York
    NYU Perlmutter Cancer Center
Aug 5, 2022

GastroEsophageal Cancer Trial in Boston (Irinotecan, Oxaliplatin, Leucovorin)

Active, not recruiting
Has Results
  • GastroEsophageal Cancer
  • Boston, Massachusetts
    Massachusetts General Hospital
Sep 7, 2022

Pancreatic Cancer, Pancreatic Adenocarcinoma, Pancreas Ductal Adenocarcinoma Trial in United States (Nab-paclitaxel and

Active, not recruiting
  • Pancreatic Cancer
  • +2 more
  • Nab-paclitaxel and gemcitabine for R-PDAC Patients
  • Nab-paclitaxel and gemcitabine for BR-PDAC Patients
  • Scottsdale, Arizona
  • +3 more
Mar 8, 2022

Endometrial Cancer Trial in New York (Carboplatin AUC, Abraxane)

Completed
Has Results
  • Endometrial Cancer
  • Carboplatin AUC
  • Abraxane
  • New York, New York
    NYU Perlmutter Cancer Center
Apr 20, 2021

Metastatic Pancreatic Cancer Trial in Scottsdale (diagnostic test, other, drug)

Completed
  • Metastatic Pancreatic Cancer
  • Safety Laboratories
  • +7 more
  • Scottsdale, Arizona
    HonorHealth Research Institute
Jul 14, 2021

Pancreatic Cancer Trial in Houston (genetic, drug, biological)

Recruiting
  • Pancreatic Cancer
  • delolimogene mupadenorepvec
  • +3 more
  • Houston, Texas
  • +1 more
Sep 16, 2022

Unresectable Locally Advanced or Metastatic Pancreatic Cancer Trial in Shanghai (surufatinib, KN046, gemcitabine)

Not yet recruiting
  • Unresectable Locally Advanced or Metastatic Pancreatic Cancer
  • Shanghai, Shanghai, China
    Zhongshan Hospital
Apr 16, 2023

Triple Negative Breast Cancer Metastatic Trial in Milano, Padova (Ceralasertib, Durvalumab, Nab-paclitaxel)

Recruiting
  • Triple Negative Breast Cancer Metastatic
  • Milano, Italy
  • +1 more
Jan 16, 2023

Solid Tumors Trial in United States (CORT125134 with nab-paclitaxel)

Completed
Has Results
  • Solid Tumors
  • Relacorilant with nab-paclitaxel
  • Scottsdale, Arizona
  • +3 more
Nov 9, 2022

Pancreatic Cancer, Stage IB, Pancreatic Cancer, Stage IIA, Pancreatic Cancer, Stage IIB Trial in Shanghai (sintilimab,

Not yet recruiting
  • Pancreatic Cancer, Stage IB
  • +3 more
  • Shanghai, Shanghai, China
    Zhongshan Hospital
Jan 4, 2023

Head and Neck Squamous Cell Carcinoma Trial (Nab-paclitaxel, Cisplatin, Tislelizumab)

Not yet recruiting
  • Head and Neck Squamous Cell Carcinoma
  • (no location specified)
Aug 23, 2022

Locally Advanced Pancreatic Cancer (LAPC) Trial in Herlev (Gemcitabine, Nab-paclitaxel, Nivolumab)

Recruiting
  • Borderline Resectable, Locally Advanced or Metastatic Pancreatic Cancer
  • Herlev, Denmark
    Herlev & Gentofte University Hospital, Denmark
Oct 13, 2022

Pancreatic Adenocarcinoma Trial in Hamilton (mFOLFIRINOX, Gemcitabine / Nab-paclitaxel)

Recruiting
  • Pancreatic Adenocarcinoma
  • Hamilton, Ontario, Canada
    Juravinski Hospital
Aug 5, 2022

Metastatic Breast Cancer Trial in Shanghai (Abraxane)

Completed
  • Metastatic Breast Cancer
  • Abraxane
  • Shanghai, China
    Fudan University Cancer Hospital
Feb 25, 2021